New Mexico Educational Retirement Board lessened its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,135 shares of the financial services provider’s stock after selling 500 shares during the period. New Mexico Educational Retirement Board’s holdings in CME Group were worth $3,979,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Franklin Resources Inc. boosted its holdings in shares of CME Group by 70.4% during the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after buying an additional 1,003,119 shares during the period. International Assets Investment Management LLC increased its stake in CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock valued at $1,072,070,000 after acquiring an additional 483,618 shares during the period. Canoe Financial LP grew its position in CME Group by 698.0% in the fourth quarter. Canoe Financial LP now owns 544,219 shares of the financial services provider’s stock valued at $126,384,000 after acquiring an additional 476,019 shares during the period. Janus Henderson Group PLC lifted its holdings in CME Group by 17.8% during the 3rd quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock valued at $554,707,000 after purchasing an additional 380,071 shares during the last quarter. Finally, Baillie Gifford & Co. acquired a new position in shares of CME Group in the 3rd quarter worth approximately $79,692,000. Institutional investors own 87.75% of the company’s stock.
Insider Activity at CME Group
In other news, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now directly owns 21,885 shares of the company’s stock, valued at $5,453,085.45. This represents a 34.63 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.30% of the stock is owned by corporate insiders.
CME Group Price Performance
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.39% and a net margin of 57.34%. Equities research analysts anticipate that CME Group Inc. will post 10.18 earnings per share for the current year.
CME Group declared that its board has initiated a stock buyback plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board believes its shares are undervalued.
CME Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date is Friday, March 7th. This is an increase from CME Group’s previous quarterly dividend of $1.15. CME Group’s payout ratio is currently 51.71%.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on CME shares. Barclays increased their price objective on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research report on Thursday. Piper Sandler raised their price target on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Keefe, Bruyette & Woods increased their target price on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a report on Friday. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Finally, Oppenheimer increased their price target on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $234.13.
Check Out Our Latest Stock Analysis on CME
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- Conference Calls and Individual Investors
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- What Are the FAANG Stocks and Are They Good Investments?
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.